E-LIB Suche - Ergebnisse für: Al-Ali, Haifa Kathrin

1

Prognostic impact of the bone marrow tumor microenvironment..:

Bauer, Marcus ; Jäkel, Nadja ; Wilfer, Andreas...
OncoImmunology. 13 (2024) 1 - p. , 2024

2

ROP-ET: a prospective phase III trial investigating the eff..:

Kiladjian, Jean-Jacques ; Marin, Francisca Ferrer ; Al-Ali, Haifa Kathrin...
Annals of Hematology. 103 (2024) 7 - p. 2299-2310 , 2024

Link: https://doi.org/10.1007/..

3

FRACTION: protocol of a phase II study of Fedratinib and Ni..:

Isfort, Susanne ; von Bubnoff, Nikolas ; Al-Ali, Haifa Kathrin...
Annals of Hematology. , 2024

Link: https://doi.org/10.1007/..

4

Step-in dosing of bosutinib in pts with chronic phase chron..:

Isfort, Susanne ; Manz, Kirsi ; Teichmann, Lino L....
Annals of Hematology. 102 (2023) 10 - p. 2741-2752 , 2023

Link: https://doi.org/10.1007/..

5

PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCO..:

Al-Ali, Haifa Kathrin ; Mesa, Ruben ; Hamer-Maansson, J.E...
HemaSphere. 7 (2023) S3 - p. e85817f0 , 2023

Link: https://doi.org/10.1097/..

6

Anxieties, age and motivation influence physical activity i..:

Felser, Sabine ; Rogahn, Julia ; le Coutre, Philipp...
Frontiers in Oncology. 12 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Momelotinib versus danazol in symptomatic patients with ana..:

Verstovsek, Srdan ; Gerds, Aaron T ; Vannucchi, Alessandro M...
The Lancet. 401 (2023) 10373 - p. 269-280 , 2023

Link: https://doi.org/10.1016/..

8

Different treatment strategies versus a common standard arm..:

Niederwieser, Dietger ; Lang, Thomas ; Krahl, Rainer...
Annals of Hematology. 102 (2023) 3 - p. 547-561 , 2023

Link: https://doi.org/10.1007/..

9

Vector-based SARS-CoV-2 vaccination is associated with impr..:

Engelmann, Robby ; Jaekel, Nadja ; Jotschke, Sabrina...
Blood Advances. 7 (2023) 14 - p. 3403-3415 , 2023

Link: https://doi.org/10.1182/..

10

Activity of decitabine combined with all-trans retinoic aci..:

Rummelt, Christoph ; Grishina, Olga ; Schmoor, Claudia...
Haematologica. 108 (2023) 8 - p. 2244-2248 , 2023

Link: https://doi.org/10.3324/..

11

Benefit of Early Ruxolitinib Initiation Regardless of Fibro..:

Palandri, Francesca ; Al-Ali, Haifa Kathrin ; Guglielmelli, Paola...
Cancers. 15 (2023) 10 - p. 2859 , 2023

Link: https://doi.org/10.3390/..

12

S214: DISEASE-MODIFYING ACTIVITY OF NAVTEMADLIN (NVTM) CORR..:

Vachhani, Pankit ; Perkins, Andrew ; Mascarenhas, John...
HemaSphere. 7 (2023) S3 - p. e05521ca , 2023

Link: https://doi.org/10.1097/..

13

S213: BMS-986158, A POTENT BET INHIBITOR, AS MONOTHERAPY AN..:

Ayala, Rosa ; Lopez, Nieves ; Abulafia, Adi Shacham...
HemaSphere. 7 (2023) S3 - p. e4785165 , 2023

Link: https://doi.org/10.1097/..

14

PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACT..:

Montesinos, Pau ; Al-Ali, Haifa Kathrin ; Dominguez, Juan Manuel Alonso...
HemaSphere. 7 (2023) S3 - p. e451088e , 2023

Link: https://doi.org/10.1097/..

15

MPN-478 MOMENTUM: Phase 3 Randomized Study of Momelotinib (..:

Mesa, Ruben ; Gerds, Aaron ; Vannucchi, Alessandro...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S339-S340 , 2022

Link: https://doi.org/10.1016/..